Squarepoint’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,554
| Closed | -$257K | – | 3284 |
|
|
2024
Q4 | $257K | Sell |
6,554
-950
| -13% | -$37.2K | ﹤0.01% | 2271 |
|
|
2024
Q3 | $295K | Buy |
+7,504
| New | +$295K | ﹤0.01% | 2009 |
|
|
2024
Q1 | – | Sell |
-8,253
| Closed | -$380K | – | 2997 |
|
|
2023
Q4 | $380K | Buy |
+8,253
| New | +$380K | ﹤0.01% | 1848 |
|
|
2022
Q4 | – | Sell |
-10,605
| Closed | -$383K | – | 2663 |
|
|
2022
Q3 | $383K | Buy |
10,605
+3,555
| +50% | +$128K | ﹤0.01% | 1506 |
|
|
2022
Q2 | $214K | Buy |
+7,050
| New | +$214K | ﹤0.01% | 1710 |
|
|
2022
Q1 | – | Sell |
-11,014
| Closed | -$344K | – | 2899 |
|
|
2021
Q4 | $344K | Buy |
+11,014
| New | +$344K | ﹤0.01% | 1800 |
|
|
2020
Q3 | – | Sell |
-24,321
| Closed | -$305K | – | 2726 |
|
|
2020
Q2 | $305K | Buy |
24,321
+4,281
| +21% | +$53.7K | ﹤0.01% | 1557 |
|
|
2020
Q1 | $227K | Sell |
20,040
-12,037
| -38% | -$136K | 0.01% | 1418 |
|
|
2019
Q4 | $421K | Sell |
32,077
-55,023
| -63% | -$722K | ﹤0.01% | 1815 |
|
|
2019
Q3 | $785K | Sell |
87,100
-5,890
| -6% | -$53.1K | 0.01% | 1345 |
|
|
2019
Q2 | $917K | Buy |
92,990
+60,863
| +189% | +$600K | 0.01% | 1294 |
|
|
2019
Q1 | $326K | Buy |
+32,127
| New | +$326K | ﹤0.01% | 1687 |
|